Aboagye EO - Search Results

1

Bench to Bedside Development of [¹⁸F]Fluoromethyl-(1,2-²H₄)choline ([¹⁸F]D4-FCH).

Challapalli A, Barwick TD, Dubash SR, Inglese M, Grech-Sollars M, Kozlowski K, Tam H, Patel NH, Winkler M, Flohr P, Saleem A, Bahl A, Falconer A, De Bono JS, Aboagye EO, Mangar S. Challapalli A, et al. Among authors: aboagye eo. Molecules. 2023 Dec 8;28(24):8018. doi: 10.3390/molecules28248018. Molecules. 2023. PMID: 38138508 Free PMC article. Review.

2

In vivo monitoring of drugs using radiotracer techniques.

Saleem A, Aboagye EO, Price PM. Saleem A, et al. Among authors: aboagye eo. Adv Drug Deliv Rev. 2000 Mar 15;41(1):21-39. doi: 10.1016/s0169-409x(99)00054-x. Adv Drug Deliv Rev. 2000. PMID: 10699303 Review.

3

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action.

Saleem A, Yap J, Osman S, Brady F, Suttle B, Lucas SV, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: aboagye eo. Lancet. 2000 Jun 17;355(9221):2125-31. doi: 10.1016/s0140-6736(00)02380-1. Lancet. 2000. PMID: 10902627 Clinical Trial.

4

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.

Saleem A, Harte RJ, Matthews JC, Osman S, Brady F, Luthra SK, Brown GD, Bleehen N, Connors T, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: aboagye eo. J Clin Oncol. 2001 Mar 1;19(5):1421-9. doi: 10.1200/JCO.2001.19.5.1421. J Clin Oncol. 2001. PMID: 11230487 Clinical Trial.

5

Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.

Aboagye EO, Saleem A, Cunningham VJ, Osman S, Price PM. Aboagye EO, et al. Cancer Res. 2001 Jul 1;61(13):4937-41. Cancer Res. 2001. PMID: 11431319

6

Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.

Brady F, Luthra SK, Brown GD, Osman S, Aboagye E, Saleem A, Price PM. Brady F, et al. Curr Pharm Des. 2001 Dec;7(18):1863-92. doi: 10.2174/1381612013396907. Curr Pharm Des. 2001. PMID: 11772355 Review.

7

Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.

Propper DJ, de Bono J, Saleem A, Ellard S, Flanagan E, Paul J, Ganesan TS, Talbot DC, Aboagye EO, Price P, Harris AL, Twelves C. Propper DJ, et al. Among authors: aboagye eo. J Clin Oncol. 2003 Jan 15;21(2):203-10. doi: 10.1200/JCO.2003.02.008. J Clin Oncol. 2003. PMID: 12525511 Clinical Trial.

8

Metabolic activation of temozolomide measured in vivo using positron emission tomography.

Saleem A, Brown GD, Brady F, Aboagye EO, Osman S, Luthra SK, Ranicar AS, Brock CS, Stevens MF, Newlands E, Jones T, Price P. Saleem A, et al. Among authors: aboagye eo. Cancer Res. 2003 May 15;63(10):2409-15. Cancer Res. 2003. PMID: 12750260

9

Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.

Gupta N, Saleem A, Kötz B, Osman S, Aboagye EO, Phillips R, Vernon C, Wasan H, Jones T, Hoskin PJ, Price PM. Gupta N, et al. Among authors: aboagye eo. Clin Cancer Res. 2006 May 15;12(10):3115-23. doi: 10.1158/1078-0432.CCR-05-0513. Clin Cancer Res. 2006. PMID: 16707610 Free article. Clinical Trial.

10

Plasma pharmacokinetic evaluation of cytotoxic agents radiolabelled with positron emitting radioisotopes.

Saleem A, Aboagye EO, Matthews JC, Price PM. Saleem A, et al. Among authors: aboagye eo. Cancer Chemother Pharmacol. 2008 Apr;61(5):865-73. doi: 10.1007/s00280-007-0552-2. Epub 2007 Jul 18. Cancer Chemother Pharmacol. 2008. PMID: 17639391 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page